Although the exact mechanisms remain unclear, this study confirms that SA1 can inhibit tumor progression by modulating APOB-related lipid metabolism processes, indicating that APOB is a promising new target worthy of further investigation. This evidence concerns the gene STAG1 and neoplasm.